Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Characterizing the molecular and spatial interactions between carcinoma-associated fibroblasts (CAF), immune cells, and tumour cells in metastases of triple negative breast cancer

EF 2023-24

Résumé
Breast cancer is a widespread and often deadly disease, killing over 5000 people a year in Canada alone. When cancer cells from the initial tumour in the breast travel to other parts of the body to form secondary tumours, or metastases, the chances of survival drop drastically. In cases where tumour cells are not dependent on the estrogen or progesterone hormones, and make either very little or none of a protein called HER2, the disease is referred to as "triple-negative breast cancer". Triple negative breast cancer tumours grow extremely quickly and are unresponsive to common drugs meant to target the estrogen or HER2; therefore, chemotherapy is the main treatment used in these cases. Over time, tumour cells can develop resistance to chemotherapy and make it ineffective, resulting in patient death. Within the tumour stroma, or the tissues around the cancer cells that hold the tumour together, there are a variety of different cell types, including immune cells to fight infection, and fibroblasts to create connective tissue to provide a scaffold for the tumor. These cancer-associated fibroblasts have been shown recently to protect the surrounding cancer cells from chemotherapy and the body's own immune system. The purpose of this novel project is to examine how these cancer-associated fibroblasts interact with immune cells around the tumour, and study how their interplay contributes to the development of chemotherapy resistance. We will also investigate the similarities and differences between primary tumours and metastases. It is necessary to understand these interactions to be able to develop new therapies to overcome resistance to chemotherapy and improve patient outcomes in triple negative breast cancer cases.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
497125
Name
Goudreau Alexandra
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Characterizing the molecular and spatial interactions between carcinoma-associated fibroblasts (CAF), immune cells, and tumour cells in metastases of triple negative breast cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Chemotherapy Resistance; Tumour Immune Microenvironment; Tumour Stroma
Abstract
Breast cancer is a widespread and often deadly disease, killing over 5000 people a year in Canada alone. When cancer cells from the initial tumour in the breast travel to other parts of the body to form secondary tumours, or metastases, the chances of survival drop drastically. In cases where tumour cells are not dependent on the estrogen or progesterone hormones, and make either very little or none of a protein called HER2, the disease is referred to as "triple-negative breast cancer". Triple negative breast cancer tumours grow extremely quickly and are unresponsive to common drugs meant to target the estrogen or HER2; therefore, chemotherapy is the main treatment used in these cases. Over time, tumour cells can develop resistance to chemotherapy and make it ineffective, resulting in patient death. Within the tumour stroma, or the tissues around the cancer cells that hold the tumour together, there are a variety of different cell types, including immune cells to fight infection, and fibroblasts to create connective tissue to provide a scaffold for the tumor. These cancer-associated fibroblasts have been shown recently to protect the surrounding cancer cells from chemotherapy and the body's own immune system. The purpose of this novel project is to examine how these cancer-associated fibroblasts interact with immune cells around the tumour, and study how their interplay contributes to the development of chemotherapy resistance. We will also investigate the similarities and differences between primary tumours and metastases. It is necessary to understand these interactions to be able to develop new therapies to overcome resistance to chemotherapy and improve patient outcomes in triple negative breast cancer cases.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Goudreau, Alexandra
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~